日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pioneering protein degradation for agricultural applications.

开创蛋白质降解在农业应用领域的先河

Morgan Gina L, Dickson Hamilton, Ford Breanna, Noras Aleksandra, Bremmer Steven C, Watts Brian E, Pilotte Joseph, Anderson Ed, Sullivan Eric D, Stoner Mikayla, Ouedraogo Daniel, Saltzberg Daniel J, Pothula Karunakar R, Ingram Paul, Catalano John, Lillich Melina, Kolbe Carl-Christian, Pfeiffer Anne, Ladner Christopher C, Gattis Sam, Speake Jason, Voss Stephanie, Broccio Kelly, Fourches Denis

Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis

在接受 momelotinib 治疗的骨髓纤维化患者的 SIMPLIFY-1 和 SIMPLIFY-2 三期临床试验中,总生存期

Mesa, Ruben; Harrison, Claire; Oh, Stephen T; Gerds, Aaron T; Gupta, Vikas; Catalano, John; Cervantes, Francisco; Devos, Timothy; Hus, Marek; Kiladjian, Jean-Jacques; Lech-Maranda, Ewa; McLornan, Donal; Vannucchi, Alessandro M; Platzbecker, Uwe; Huang, Mei; Strouse, Bryan; Klencke, Barbara; Verstovsek, Srdan

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

来那度胺维持治疗对 R-CHOP 方案有反应的弥漫性大 B 细胞淋巴瘤患者:来自随机对照 REMARC 研究的生活质量、剂量和安全性结果

Thieblemont, Catherine; Howlett, Susannah; Casasnovas, René-Olivier; Mounier, Nicolas; Perrot, Aurore; Morschhauser, Franck; Fruchart, Christophe; Daguindau, Nicolas; van Eygen, Koen; Obéric, Lucie; Bouabdallah, Reda; Pica, Gian Matteo; Nicolas-Virezelier, Emmanuelle; Abraham, Julie; Fitoussi, Olivier; Snauwaert, Sylvia; Eisenmann, Jean-Claude; Lionne-Huyghe, Pauline; Bron, Dominique; Tricot, Sabine; Deeren, Dries; Gonzalez, Hugo; Costello, Régis; Le Du, Katell; da Silva, Maria Gomes; Grosicki, Sebastian; Trotman, Judith; Catalano, John; Caballero, Dolores; Greil, Richard; Cohen, Amos M; Gaulard, Philippe; Roulin, Louise; Takeshita, Kenichi; Casadebaig, Marie-Laure; Tilly, Hervé; Coiffier, Bertrand

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

利妥昔单抗维持治疗对滤泡性淋巴瘤患者持续无进展生存期的获益:PRIMA 研究的长期结果

Bachy, Emmanuel; Seymour, John F; Feugier, Pierre; Offner, Fritz; López-Guillermo, Armando; Belada, David; Xerri, Luc; Catalano, John V; Brice, Pauline; Lemonnier, François; Martin, Alejandro; Casasnovas, Olivier; Pedersen, Lars M; Dorvaux, Véronique; Simpson, David; Leppa, Sirpa; Gabarre, Jean; da Silva, Maria G; Glaisner, Sylvie; Ysebaert, Loic; Vekhoff, Anne; Intragumtornchai, Tanin; Le Gouill, Steven; Lister, Andrew; Estell, Jane A; Milone, Gustavo; Sonet, Anne; Farhi, Jonathan; Zeuner, Harald; Tilly, Hervé; Salles, Gilles

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

多发性骨髓瘤一线治疗3期FIRST试验生存结果的最终分析

Facon, Thierry; Dimopoulos, Meletios A; Dispenzieri, Angela; Catalano, John V; Belch, Andrew; Cavo, Michele; Pinto, Antonello; Weisel, Katja; Ludwig, Heinz; Bahlis, Nizar J; Banos, Anne; Tiab, Mourad; Delforge, Michel; Cavenagh, Jamie D; Geraldes, Catarina; Lee, Je-Jung; Chen, Christine; Oriol, Albert; De La Rubia, Javier; White, Darrell; Binder, Daniel; Lu, Jin; Anderson, Kenneth C; Moreau, Philippe; Attal, Michel; Perrot, Aurore; Arnulf, Bertrand; Qiu, Lugui; Roussel, Murielle; Boyle, Eileen; Manier, Salomon; Mohty, Mohamad; Avet-Loiseau, Herve; Leleu, Xavier; Ervin-Haynes, Annette; Chen, Guang; Houck, Vanessa; Benboubker, Lotfi; Hulin, Cyrille

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis

SIMPLIFY-1:一项比较莫美替尼与鲁索替尼治疗未接受过 Janus 激酶抑制剂治疗的骨髓纤维化患者的 III 期随机试验

Mesa, Ruben A; Kiladjian, Jean-Jacques; Catalano, John V; Devos, Timothy; Egyed, Miklos; Hellmann, Andrzei; McLornan, Donal; Shimoda, Kazuya; Winton, Elliott F; Deng, Wei; Dubowy, Ronald L; Maltzman, Julia D; Cervantes, Francisco; Gotlib, Jason

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

鲁索替尼治疗骨髓纤维化患者的长期疗效:随机、双盲、安慰剂对照的3期COMFORT-I试验5年更新结果

Verstovsek, Srdan; Mesa, Ruben A; Gotlib, Jason; Gupta, Vikas; DiPersio, John F; Catalano, John V; Deininger, Michael W N; Miller, Carole B; Silver, Richard T; Talpaz, Moshe; Winton, Elliott F; Harvey, Jimmie H Jr; Arcasoy, Murat O; Hexner, Elizabeth O; Lyons, Roger M; Paquette, Ronald; Raza, Azra; Jones, Mark; Kornacki, Deanna; Sun, Kang; Kantarjian, Hagop

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

mTOR抑制剂依维莫司联合阿扎胞苷治疗复发/难治性急性髓系白血病患者:一项Ib/II期研究

Tan, Peter; Tiong, Ing Soo; Fleming, Shaun; Pomilio, Giovanna; Cummings, Nik; Droogleever, Mark; McManus, Julie; Schwarer, Anthony; Catalano, John; Patil, Sushrut; Avery, Sharon; Spencer, Andrew; Wei, Andrew

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

基于硼替佐米的抗体清除疗法治疗难治性自身免疫性血液疾病

Ratnasingam, Sumita; Walker, Patricia A; Tran, Huy; Kaplan, Zane S; McFadyen, James D; Tran, Huyen; Teh, Tse-Chieh; Fleming, Shaun; Catalano, John V; Chunilal, Sanjeev D; Johnston, Anna; Opat, Stephen S; Shortt, Jake

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

鲁索替尼治疗骨髓纤维化患者的疗效、安全性和生存率:COMFORT-I 研究中位随访 3 年的结果

Verstovsek, Srdan; Mesa, Ruben A; Gotlib, Jason; Levy, Richard S; Gupta, Vikas; DiPersio, John F; Catalano, John V; Deininger, Michael W N; Miller, Carole B; Silver, Richard T; Talpaz, Moshe; Winton, Elliott F; Harvey, Jimmie H Jr; Arcasoy, Murat O; Hexner, Elizabeth O; Lyons, Roger M; Raza, Azra; Vaddi, Kris; Sun, William; Peng, Wei; Sandor, Victor; Kantarjian, Hagop